Fixel-based analysis links white matter characteristics, serostatus and clinical features in limbic encephalitis.


Journal

NeuroImage. Clinical
ISSN: 2213-1582
Titre abrégé: Neuroimage Clin
Pays: Netherlands
ID NLM: 101597070

Informations de publication

Date de publication:
2020
Historique:
received: 04 12 2019
revised: 22 04 2020
accepted: 24 04 2020
pubmed: 6 7 2020
medline: 30 3 2021
entrez: 6 7 2020
Statut: ppublish

Résumé

Limbic encephalitis (LE) is an autoimmune syndrome often associated with temporal lobe epilepsy. Recent research suggests that particular structural changes in LE depend on the type of the associated antibody and occur in both mesiotemporal gray matter and white matter regions. However, it remains questionable to what degree conventional diffusion tensor imaging (DTI)-methods reflect alterations in white matter microstructure, since these methods do not account for crossing fibers. To address this methodological shortcoming, we applied fixel-based analysis as a novel technique modeling distinct fiber populations. For our study, 19 patients with LE associated with autoantibodies against glutamic acid decarboxylase 65 (GAD-LE, mean age = 35.9 years, 11 females), 4 patients with LE associated with autoantibodies against leucine-rich glioma-inactivated 1 (LGI1-LE, mean age = 63.3 years, 2 females), 5 patients with LE associated with contactin-associated protein-like 2 (CASPR2, mean age = 57.4, 0 females), 20 age- and gender-matched control patients with hippocampal sclerosis (19 GAD-LE control patients: mean age = 35.1 years, 11 females; 4 LGI1-LE control patients: mean age = 52.6 years, 2 females; 5 CASPR2-LE control patients: mean age = 42.7 years, 0 females; 10 patients are included in more than one group) and 33 age- and gender-matched healthy control subjects (19 GAD-LE healthy controls: mean age = 34.6 years, 11 females; 8 LGI1-LE healthy controls: mean age = 57.0 years, 4 females, 10 CASPR2-LE healthy controls: mean age = 57.2 years, 0 females; 4 subjects are included in more than one group) underwent structural imaging and DTI at 3 T and neuropsychological testing. Patient images were oriented according to lateralization in EEG resulting in an affected and unaffected hemisphere. Fixel-based metrics fiber density (FD), fiber cross-section (FC), and fiber density and cross-section (FDC = FD · FC) were calculated to retrieve information about white matter integrity both on the micro- and the macroscale. As compared to healthy controls, patients with GAD-LE showed significantly (family-wise error-corrected, p < 0.05) lower FDC in the superior longitudinal fascicle bilaterally and in the isthmus of the corpus callosum. In CASPR2-LE, lower FDC in the superior longitudinal fascicle was only present in the affected hemisphere. In LGI1-LE, we did not find any white matter alteration of the superior longitudinal fascicle. In an explorative tract-based correlation analysis within the GAD-LE group, only a correlation between the left/right ratio of FC values of the superior longitudinal fascicle and verbal memory performance (R = 0.64, Holm-Bonferroni corrected p < 0.048) remained significant after correcting for multiple comparisons. Our results underscore the concept of LE as a disease comprising a broad and heterogeneous group of entities and contribute novel aspects to the pathomechanistic understanding of this disease that may strengthen the role of MRI in the diagnosis of LE.

Identifiants

pubmed: 32623136
pii: S2213-1582(20)30126-1
doi: 10.1016/j.nicl.2020.102289
pmc: PMC7334603
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

102289

Informations de copyright

Copyright © 2020 The Author(s). Published by Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest C.E.E. received fees as speaker or consultant from UCB Pharma, Desitin, BIAL and Eisai. R.S. has received fees as speaker or consultant from Bial, Cyberonics, Desitin, Eisai, LivaNova, Novartis, and UCB Pharma.

Références

Neurology. 2007 Sep 18;69(12):1236-44
pubmed: 17875912
Arch Neurol. 2012 May;69(5):582-93
pubmed: 22451162
Neuroimage. 2003 Oct;20(2):870-88
pubmed: 14568458
Neuroimage. 2013 Feb 15;67:298-312
pubmed: 23238430
Epilepsia. 2012 Apr;53(4):659-67
pubmed: 22379949
IEEE Trans Med Imaging. 2010 Jun;29(6):1310-20
pubmed: 20378467
Lancet Neurol. 2016 Apr;15(4):391-404
pubmed: 26906964
Brain. 2010 Sep;133(9):2734-48
pubmed: 20663977
Neuroimage. 2014 Dec;103:411-426
pubmed: 25109526
Ann Neurol. 2018 Jan;83(1):166-177
pubmed: 29293273
J Neurol. 2010 Apr;257(4):509-17
pubmed: 20035430
Neuroimage. 2017 Jan 1;144(Pt A):58-73
pubmed: 27639350
Ann Neurol. 2006 Jul;60(1):80-7
pubmed: 16802302
AJNR Am J Neuroradiol. 2009 Oct;30(9):1740-7
pubmed: 19509072
Epilepsia. 2015 Oct;56(10):1551-61
pubmed: 26249101
Nat Rev Neurol. 2017 May;13(5):290-301
pubmed: 28418022
Epilepsia. 2015 Jan;56(1):125-32
pubmed: 25545559
Brain Struct Funct. 2011 Sep;216(3):263-74
pubmed: 21538022
AJNR Am J Neuroradiol. 2019 Dec;40(12):2081-2089
pubmed: 31727746
Cortex. 1991 Dec;27(4):547-55
pubmed: 1782789
Epilepsia. 2016 Mar;57(3):475-83
pubmed: 26749370
Brain. 2016 Apr;139(Pt 4):1079-93
pubmed: 26945884
Brain. 2009 Sep;132(Pt 9):2309-16
pubmed: 19690094
Neuroradiology. 2018 Mar;60(3):239-245
pubmed: 29353399
Epilepsy Behav. 2007 Jun;10(4):529-38
pubmed: 17493878
Neurology. 2012 Sep 25;79(13):1384-91
pubmed: 22972641
Neurology. 2017 Feb 7;88(6):508-509
pubmed: 28062718
Neuroimage. 2007 Apr 15;35(3):1064-76
pubmed: 17320414
Trends Cogn Sci. 2000 Nov 1;4(11):417-423
pubmed: 11058819
Magn Reson Med. 2016 Nov;76(5):1582-1593
pubmed: 26599599
Hum Brain Mapp. 2013 Nov;34(11):2747-66
pubmed: 22611035
Ann Neurol. 2017 Feb;81(2):240-250
pubmed: 28009132
Neuroimage. 2012 Aug 15;62(2):782-90
pubmed: 21979382
Lancet Neurol. 2010 Aug;9(8):776-85
pubmed: 20580615
Proc Natl Acad Sci U S A. 2007 Oct 23;104(43):17163-8
pubmed: 17939998
Neuroimage. 2012 Feb 15;59(4):3976-94
pubmed: 22036682
Neuroimage. 2011 Jan 1;54(1):49-59
pubmed: 20682348
Ann Neurol. 2010 Apr;67(4):470-8
pubmed: 20437582
Epilepsia. 2016 Apr;57(4):590-6
pubmed: 26920755
Neuroimage. 2015 Aug 15;117:40-55
pubmed: 26004503
NMR Biomed. 2013 Dec;26(12):1775-86
pubmed: 24038308
J Neurol Neurosurg Psychiatry. 2018 May;89(5):526-534
pubmed: 29055902
Neuroscience. 2015 Nov 19;309:68-83
pubmed: 26012492
Lancet Neurol. 2006 Dec;5(12):1055-63
pubmed: 17110286
Neuron. 2002 Jan 31;33(3):341-55
pubmed: 11832223
Neuroimage. 2016 Jan 15;125:1063-1078
pubmed: 26481672
Semin Ultrasound CT MR. 2014 Oct;35(5):504-16
pubmed: 25217302
N Engl J Med. 2018 Mar 1;378(9):840-851
pubmed: 29490181
Epilepsia. 2015 May;56(5):754-61
pubmed: 25809952

Auteurs

Tobias Bauer (T)

Department of Epileptology, University Hospital Bonn, Venusberg-Campus 1, 53127 Bonn, Germany.

Leon Ernst (L)

Department of Epileptology, University Hospital Bonn, Venusberg-Campus 1, 53127 Bonn, Germany.

Bastian David (B)

Department of Epileptology, University Hospital Bonn, Venusberg-Campus 1, 53127 Bonn, Germany.

Albert J Becker (AJ)

Department of Neuropathology, University Hospital Bonn, Venusberg-Campus 1, 53127 Bonn, Germany.

Jan Wagner (J)

Department of Neurology, University of Ulm and Universitäts- and Rehabilitationskliniken, 89070 Ulm, Germany.

Juri-Alexander Witt (JA)

Department of Epileptology, University Hospital Bonn, Venusberg-Campus 1, 53127 Bonn, Germany.

Christoph Helmstaedter (C)

Department of Epileptology, University Hospital Bonn, Venusberg-Campus 1, 53127 Bonn, Germany.

Bernd Weber (B)

Institute of Experimental Epileptology and Cognition Research, University Hospital Bonn, Venusberg-Campus 1, 53127 Bonn, Germany.

Elke Hattingen (E)

Department of Neuroradiology, Goethe University Frankfurt, Schleusenweg 2, 60528 Frankfurt, Germany.

Christian E Elger (CE)

Department of Epileptology, University Hospital Bonn, Venusberg-Campus 1, 53127 Bonn, Germany.

Rainer Surges (R)

Department of Epileptology, University Hospital Bonn, Venusberg-Campus 1, 53127 Bonn, Germany.

Theodor Rüber (T)

Department of Epileptology, University Hospital Bonn, Venusberg-Campus 1, 53127 Bonn, Germany; Epilepsy Center Frankfurt Rhine-Main, Department of Neurology, Goethe University Frankfurt, Schleusenweg 2, 60528 Frankfurt, Germany; Center for Personalized Translational Epilepsy Research (CePTER), Goethe University Frankfurt, Schleusenweg 2, 60528 Frankfurt, Germany. Electronic address: theodor.rueber@ukbonn.de.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH